Vaccine Development GSK is actively involved in developing mRNA vaccines for a variety of infectious diseases, including herpes simplex, flu, and COVID-19. This presents a significant sales opportunity for companies offering complementary technologies or services in the vaccine development sector.

Partnership Investment GSK has made substantial equity investments in companies like SpringWorks Therapeutics, indicating a willingness to collaborate and invest in innovative solutions. Sales professionals can explore collaboration opportunities with GSK to offer products or services that align with their investment focus.

Legal Challenges GSK is facing legal challenges due to a whistleblower lawsuit related to products like Zantac. Legal service providers specializing in handling such cases could explore offering their expertise to GSK, presenting a sales opportunity for legal consultation and defense services.

Tech Stack Expansion With a diverse tech stack that includes DoubleClick, Tableau, and Neo4j, GSK emphasizes technology adoption. Tech companies can approach GSK with innovative solutions that complement their existing stack, offering a potential avenue for technology sales and partnerships.

Workforce Optimization Recent news of GSK reducing headcount indicates a focus on optimizing operations. HR consulting firms can target GSK with services that enhance employee engagement, streamline workforce management, and improve efficiency, creating opportunities for HR-related sales engagements.